SURFACTANT (SP-D) AND LUNG FUNCTIONAL DATA RELATIONSHIP WITH ECHOCARDIOGRAPHIC INDICATORS OF HEART ISCHEMIC AND CHRONIC OBSTRUCTIVE PULMONARY DISEASES

SURFACTANT (SP-D) AND LUNG FUNCTIONAL DATA RELATIONSHIP WITH ECHOCARDIOGRAPHIC INDICATORS OF HEART ISCHEMIC AND CHRONIC OBSTRUCTIVE PULMONARY DISEASES

Authors

DOI:

https://doi.org/10.52340/jecm.2024.01.05

Keywords:

Surfactant, lung, heart, ishemic disease, COPD

Abstract

Background: As it is well-known, cardio-vascular diseases represent one of the leading causes of mortality. This disease is frequently accompanied by the chronic obstructive pulmonary disease which extremely complicates the patient’s outcomes resulting in the increase of mortality rate. The conducted study reviews the effect of SP-D upon the coronary heart disease and chronic obstructive pulmonary disease and evaluates its relationships with the changes of echocardiographic parameters in case of the concomitant existence of these two diseases.

Methods: The cohort of 90 patients were included in the study. The patients were divided into five groups: group I (patients with CHD); group II (patients with dyslipidemia); group III (patients with COPD); group IV (patients with CHD and COPD); group V (control group). For the purpose of inclusion of patients in the above-mentioned groups, the study utilized the laboratory (dyslipidemia - enzymatic methods) as well as the instrumental methods (echocardiography, the pulmonary function tests were determined through spirometry test).

Results: The highest incidence of SP-D was identified in the group of combined CHD and COPD (35,1±16,7); The high value of circulated SP-D, which statistically differed from other groups, clearly illustrated its effect on the clinical condition of a patient in case of COPD and CHD combination, when there was detected the pulmonary function impairment FEV1-56.2±12.7, FVC-61.2±11.4 and FEV1/FVC 0.709±0.10 as well as the positive correlation between SP-D and FEVI indicating the exacerbation of obstruction during the concomitant CHD. According to the present study, the changes were observed in the echocardiographic data, namely, the reduced ejection fraction (EF%) in the IV – combined CHD and COPD group and the increased ventricular size in the same group. Conclusion: In COPD, the left ventricular functions as well as the right ventricle are impaired prior to the distinct clinical manifestation of heart disease and the echocardiographic parameters are in correlation with the functional parameters of COPD patients.

Downloads

Download data is not yet available.

References

Global Initiative for Chronic Obstructive Lung Disease–Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary disease. http.//www.goldcopd.com. [Accessed on 24-04-2017].

Higham MA, Dawson D, Joshi J, Paulos PN, Morell NW. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Euro Resp J. 2001;17:350-55.

Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease, evaluation and management. Chest. 1991;99:715-23.

Garrad CS, Lourenco RV, Mucociliary clearance. Chapter 2 HugoD Montenegro. Contemporary issues in pulmonary diseases- Chronic Obstructive Pulmonary Disease Vol. 1. Churchill Livingstone. Newyork. 1984:29-48.

Ian TT, Higgins. Epidemiology of Bronchitis and Emphysema. Chapter 36 Pulmonary Diseases and Disorders. Alfred P Fishman vol. 1, McGraw-Hill Inc USA, 1980:470-75.

Kulkarni KD, Mahesh PA . Left Ventricular and Right Ventricular Functional Changes in Cases of COPD and its Correlation with Severity A Cross-sectional Study2022 Jan, Vol-16(1): OC20-OC23

2022 AHA/ACC/HFSA Guidline for the Management of Heart Failure; A report of he American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Back M. Atherosclerosis, COPD and chronic inflammation. Respir Med COPD Update. 2008;4:60–65.

Steven A. Echo in Pulmonary HTN; https://www.asecho.org/wp-content/uploads/2017/10/10-Pulm-HTN-Florida_2017.pdf

Chris NicksonJan 31, 2023; Pulmonary Hypertension Echocardiography; https://litfl.com/pulmonary-hypertension-echocardiography/

THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION IN ADULTS https://www.asecho.org/wp-content/uploads/2018/08/WFTF-Chamber-Quantification-Summary-Doc-Final-July-18.pdf

European Respiratory Journal 2015 46: 903-975; DOI: 10.1183/13993003.01032-2015; 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension https://erj.ersjournals.com/content/46/4/903

https://www.asecho.org/wp-content/uploads/2013/05/Echo-Assessment-of-Right-Heart-in-Adults.pdf

Agudelo C.W, Samaha G & Garcia I-Arcos; Alveolar lipids in pulmonary disease; BMC; Published: 03 June 2020

Otaki Y; Tetsu Watanabe T. Circulating Surfactant Protein-D Is Associated With Clinical Outcomes in Peripheral Artery Disease Patients Following Endovascular Therapy. Circ J 2018; 82: 1926–1934 doi:10.1253/circj.CJ-17-1446

Sahay S. Evaluation and classification of pulmonary arterial hypertension. J Thorac Dis. 2019 Sep; 11(Suppl 14): S1789–S179 doi: 10.21037/jtd.2019.08.54

Mosenifar Z. Pulmonary Arterial Hypertension. Drugs & Diseases > Pulmonology.Updated: Feb 06, 2023.

Kumar H, Verma A, Pandey A, Srivastava U, Pandey M, Chaudhary R, et al. Echocardiographic evaluation of stable J Clin Diag Res (COPD) patients. J Assoc Chest Physicians. 2020;8:88-91

Wilke SH, Spruit MA, Uszko-Lencer NMHK, Otkinska G, Vanfleteren LE, Jones PW, et al Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation Respirology. 2017;22:928–934

Galiè N, McLaughlin VV, Rubin LJ, et al. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J 2019;53:1802148. 10.1183/13993003.02148-2018

Downloads

Published

2024-03-11

How to Cite

ZUBIASHVILI, M., KAKAURIDZE, N., MACHAVARIANI, P., & ZUBIASHVILI, T. (2024). SURFACTANT (SP-D) AND LUNG FUNCTIONAL DATA RELATIONSHIP WITH ECHOCARDIOGRAPHIC INDICATORS OF HEART ISCHEMIC AND CHRONIC OBSTRUCTIVE PULMONARY DISEASES. Experimental and Clinical Medicine Georgia, (1), 35–48. https://doi.org/10.52340/jecm.2024.01.05

Issue

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Loading...